Inventor · disambiguated record
Alireza Rezania
Also filed as: REZANIA ALIREZA
68 granted patents·38 pending applications·6,901 citations·filing 2000–2025
99Inventor score
Top patents by PatentIndex Score
106 records- 0199US7091191B2Modified hyaluronic acid for use in musculoskeletal tissue repairETHICON INC·Filed 2003·Granted Aug 15, 2006·806 cites·6 claims
- 0299US6884428B2Use of reinforced foam implants with enhanced integrity for soft tissue repair and regenerationDEPUY MITEK INC·Filed 2002·Granted Apr 26, 2005·1.3k cites·19 claims
- 0399US6852330B2Reinforced foam implants with enhanced integrity for soft tissue repair and regenerationDEPUY MITEK INC·Filed 2000·Granted Feb 8, 2005·1.4k cites·17 claims
- 0498US11008586B2Universal donor cellsCRISPR THERAPEUTICS AG·Filed 2020·Granted May 18, 2021·10 cites·25 claims
- 0598US10865424B2Universal donor cellsCRISPR THERAPEUTICS AG·Filed 2020·Granted Dec 15, 2020·18 cites·16 claims
- 0698US8366787B2Hybrid biologic-synthetic bioabsorbable scaffoldsDEPUY PRODUCTS INC·Filed 2002·Granted Feb 5, 2013·1.1k cites·12 claims
- 0798US6599323B2Reinforced tissue implants and methods of manufacture and useETHICON INC·Filed 2000·Granted Jul 29, 2003·1.6k cites·26 claims
- 0897US11434505B2Universal donor cellsCRISPR THERAPEUTICS AG·Filed 2021·Granted Sep 6, 2022·6 cites·28 claims
- 0997US11433103B2Universal donor cellsCRISPR THERAPEUTICS AG·Filed 2021·Granted Sep 6, 2022·6 cites·22 claims
- 1097US11180776B1Universal donor cellsCRISPR THERAPEUTICS AG·Filed 2021·Granted Nov 23, 2021·6 cites·27 claims
- 1197US11118195B2Universal donor cellsCRISPR THERAPEUTICS AG·Filed 2020·Granted Sep 14, 2021·9 cites·26 claims
- 1297US11116797B2Universal donor cellsCRISPR THERAPEUTICS AG·Filed 2020·Granted Sep 14, 2021·9 cites·19 claims
- 1397US11118196B2Universal donor cellsCRISPR THERAPEUTICS AG·Filed 2020·Granted Sep 14, 2021·9 cites·25 claims
- 1497US11104918B2Universal donor cellsCRISPR THERAPEUTICS AG·Filed 2020·Granted Aug 31, 2021·9 cites·28 claims
- 1597US11008587B2Universal donor cellsCRISPR THERAPEUTICS AG·Filed 2020·Granted May 18, 2021·9 cites·16 claims
- 1697US10724052B2Universal donor cellsCRISPR THERAPEUTICS AG·Filed 2019·Granted Jul 28, 2020·21 cites·16 claims
- 1797US10138465B2Differentiation of human embryonic stem cells into pancreatic endocrine cells using HB9 regulatorsJANSSEN BIOTECH INC·Filed 2013·Granted Nov 27, 2018·22 cites·53 claims
- 1896US12427170B2Universal donor cellsCRISPR THERAPEUTICS AG·Filed 2022·Granted Sep 30, 2025·2 cites·29 claims
- 1996US12365915B2Universal donor cellsCRISPR THERAPEUTICS AG·Filed 2021·Granted Jul 22, 2025·2 cites·19 claims
- 2096US11578309B2Universal donor cellsCRISPR THERAPEUTICS AG·Filed 2021·Granted Feb 14, 2023·7 cites·16 claims
- 2196US11566230B2Universal donor cellsCRISPR THERAPEUTICS AG·Filed 2021·Granted Jan 31, 2023·9 cites·22 claims
- 2296US11459372B2Gene-edited natural killer cellsCRISPR THERAPEUTICS AG·Filed 2021·Granted Oct 4, 2022·3 cites·26 claims
- 2396US10358628B2Differentiation of human embryonic stem cells into single hormonal insulin positive cellsJANSSEN BIOTECH INC·Filed 2015·Granted Jul 23, 2019·10 cites·35 claims
- 2495US10947511B2Differentiation of human embryonic stem cells into pancreatic endocrine cells using thyroid hormone and/or alk5, an inhibitor of tgf-beta type 1 receptorJANSSEN BIOTECH INC·Filed 2018·Granted Mar 16, 2021·6 cites·12 claims
- 2595US7192604B2Implantable biodegradable devices for musculoskeletal repair or regenerationETHICON INC·Filed 2001·Granted Mar 20, 2007·200 cites·28 claims
- 2694US10494609B2Use of a TGF-βR-1 kinase to produce human pancreatic endocrine cellsJANSSEN BIOTECH INC·Filed 2018·Granted Dec 3, 2019·9 cites·16 claims
- 2794US9528090B2Differentiation of human embryonic stem cellsREZANIA ALIREZA·Filed 2011·Granted Dec 27, 2016·15 cites·17 claims
- 2893US10006006B2Use of small molecules to enhance MAFA expression in pancreatic endocrine cellsJANSSEN BIOTECH INC·Filed 2015·Granted Jun 26, 2018·7 cites·20 claims
- 2993US9062290B2Differentiation of human embryonic stem cellsREZANIA ALIREZA·Filed 2008·Granted Jun 23, 2015·18 cites·43 claims
- 3092US11591381B2Gene-edited natural killer cellsCRISPR THERAPEUTICS AG·Filed 2021·Granted Feb 28, 2023·2 cites·27 claims
- 3191US10066210B2Differentiation of human embryonic stem cells into pancreatic endocrine cellsJANSSEN BIOTECH INC·Filed 2013·Granted Sep 4, 2018·7 cites·9 claims
- 3291US2025230414A1Differentiation of human embryonic stem cells into single hormonal insulin positive cellsJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 3390US12378572B2Universal donor cellsCRISPR THERAPEUTICS AG·Filed 2019·Granted Aug 5, 2025·2 cites·17 claims
- 3490US9725699B2Differentiation of human embryonic stem cellsLIFESCAN INC·Filed 2014·Granted Aug 8, 2017·5 cites·8 claims
- 3590US8691259B2Reinforced foam implants with enhanced integrity for soft tissue repair and regenerationBOWMAN STEVEN M·Filed 2005·Granted Apr 8, 2014·19 cites·21 claims
- 3690US2024101963A1Sc-beta cells and compositions and methods for generating the sameHARVARD COLLEGE·Filed 2023·Application pending·0 cites
- 3789US10633635B2Methods for production of functional beta cellsJANSSEN BIOTECH INC·Filed 2017·Granted Apr 28, 2020·4 cites·43 claims
- 3889US9234178B2Differentiation of human pluripotent stem cellsREZANIA ALIREZA·Filed 2009·Granted Jan 12, 2016·8 cites·2 claims
- 3989US8741643B2Differentiation of pluripotent stem cells to definitive endoderm lineageREZANIA ALIREZA·Filed 2007·Granted Jun 3, 2014·7 cites·1 claims
- 4088US10870832B2Use of small molecules to enhance MAFA expression in pancreatic endocrine cellsJANSSEN BIOTECH INC·Filed 2018·Granted Dec 22, 2020·2 cites·16 claims
- 4188US9458430B2Differentiation of pluripotent stem cellsJANSSEN BIOTECH INC·Filed 2015·Granted Oct 4, 2016·3 cites·20 claims
- 4287US2024417692A1Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulatorsJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 4386US9593307B2Defined media for expansion and maintenance of pluripotent stem cellsJANSSEN BIOTECH INC·Filed 2016·Granted Mar 14, 2017·2 cites·13 claims
- 4486US9388386B2Differentiation of human embryonic stem cells into single hormonal insulin positive cellsJANSSEN BIOTECH INC·Filed 2012·Granted Jul 12, 2016·3 cites·6 claims
- 4586US2024002807A1Differentiation of human embryonic stem cellsJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 4685US9388387B2Differentiation of human embryonic stem cellsJANSSEN BIOTECH INC·Filed 2015·Granted Jul 12, 2016·4 cites·17 claims
- 4785US9181528B2Differentiation of pluripotent stem cellsREZANIA ALIREZA·Filed 2011·Granted Nov 10, 2015·4 cites·22 claims
- 4885US9012218B2Differentiation of human embryonic stem cellsREZANIA ALIREZA·Filed 2009·Granted Apr 21, 2015·6 cites·12 claims
- 4984US7625581B2Tissue scaffolds for use in muscoloskeletal repairsETHICON INC·Filed 2003·Granted Dec 1, 2009·43 cites·18 claims
- 5083US12215354B2Differentiation of human embryonic stem cells into single hormonal insulin positive cellsJANSSEN BIOTECH INC·Filed 2022·Granted Feb 4, 2025·0 cites·16 claims
Showing the top 50 of 106 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Alireza Rezania files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →